Canada Pension Plan Investment Board’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-35,109
Closed -$1.75M 1510
2019
Q3
$1.75M Buy
+35,109
New +$1.4M ﹤0.01% 872
2019
Q2
Sell
-29,700
Closed -$830K 1627
2019
Q1
$830K Hold
29,700
﹤0.01% 1123
2018
Q4
$568K Hold
29,700
﹤0.01% 1131
2018
Q3
$888K Hold
29,700
﹤0.01% 1105
2018
Q2
$1.09M Buy
+29,700
New +$965K ﹤0.01% 1058
2016
Q2
Sell
-5,600
Closed -$178K 1186
2016
Q1
$178K Sell
5,600
-55,500
-91% -$1.81M ﹤0.01% 1010
2015
Q4
$2.28M Buy
61,100
+39,100
+178% +$1.48M 0.01% 690
2015
Q3
$835K Sell
22,000
-11,300
-34% -$397K ﹤0.01% 873
2015
Q2
$953K Buy
33,300
+400
+1% +$11.1K ﹤0.01% 843
2015
Q1
$922K Buy
+32,900
New +$924K ﹤0.01% 860

Other funds holding MDCO

Canada Pension Plan Investment Board's MDCO Position: Q4 2019 in Review

Canada Pension Plan Investment Board sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 35,109 shares — an estimated $1.75M sold.

Canada Pension Plan Investment Board first reported a position in MDCO in Q1 2015 and held it in 10 quarters. The position peaked at $2.28M in Q4 2015. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Canada Pension Plan Investment Board reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 35,109 Medicines Co shares in Q4 2019, an estimated $1.75M.
  • Canada Pension Plan Investment Board first reported a position in Medicines Co in Q1 2015 and held it in 10 quarters.
  • Canada Pension Plan Investment Board's Medicines Co position peaked at $2.28M in Q4 2015.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Canada Pension Plan Investment Board's 13F filing for Q4 2019, filed 14 Feb 2020.